Status:
COMPLETED
Vitamin D Supplementation in Systemic Lupus Erythematosus
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Vitamin D Deficiency
Eligibility:
All Genders
18+ years
Brief Summary
Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disorder. It mainly involves the skin, the joints, the nervous system and the kidney and may be life threatening. SLE is associated with pr...
Detailed Description
Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disorder. It mainly involves the skin, the joints, the nervous system and the kidney and may be life threatening. SLE is associated with pr...
Eligibility Criteria
Inclusion
- Systemic lupus erythematosus
- Age \> 18 years
- Serum vitamin D levels \[25(OH)D\] \< 30 ng/mL
- Low to moderate active disease without modification of associated treatments
Exclusion
- Pregnancy
- Serum 25(OH)D levels \> 30 ng/mL
- Flare requiring modification of treatments
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01413230
Start Date
January 1 2010
End Date
January 1 2011
Last Update
November 24 2011
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Pitie Salpetriere
Paris, France, 75013
2
Hopital la Pitie Salpétrière
Paris, France, 75013
3
Nathalie Costedoat-Chalumeau
Paris, France, 75013